Addiction & Criminology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective - Addiction & Criminology (2024) Volume 7, Issue 2

Unpacking the complexities of prescription Opioid use.

Tara Kolla *

Institute for Health Policy, University of Toronto, Canada

*Corresponding Author:
Tara Kolla
Institute for Health Policy, University of Toronto, Canada

Received: 02-Apr -2024, Manuscript No. AARA-24-132268; Editor assigned: 03-Apr-2024, PreQC No. AARA-24-132268 (PQ); Reviewed:17-Apr-2024, QC No. AARA-24-132268; Revised:22-Apr-2024, Manuscript No. AARA-24-132268 (R); Published:29-Apr-2024, DOI:10.35841/aara-7.2.198

Citation: Kolla T, Unpacking the complexities of prescription Opioid use. Addict Criminol. 2024;7(2):198

Visit for more related articles at Addiction & Criminology


Prescription opioid use has become a topic of increasing concern globally due to its widespread impact on public health and safety. While opioids can effectively manage pain when used appropriately, their misuse and addiction have led to a devastating opioid epidemic. In this article, we delve into the complexities surrounding prescription opioid use, including their benefits, risks, prevalence, contributing factors, and strategies for addressing the opioid crisis [1].

These medications work by binding to opioid receptors in the brain and spinal cord, blocking pain signals and producing feelings of euphoria and relaxation. While opioids can provide effective pain relief, they also carry a high risk of dependence, addiction, overdose, and death when misused or taken in high doses [2].

The widespread availability and overprescribing of prescription opioids have contributed to a significant rise in opioid-related deaths and addiction rates worldwide. In the United States alone, an estimated 2.1 million people suffer from opioid use disorder, with over 70,000 overdose deaths reported annually. The opioid epidemic has strained healthcare systems, devastated families and communities, and imposed substantial economic and societal costs [3].

Several factors have contributed to the rise of prescription opioid misuse and addiction. These include aggressive marketing by pharmaceutical companies, inadequate prescribing practices by healthcare providers, lack of access to non-opioid pain management alternatives, socioeconomic disparities, stigma surrounding addiction, and the availability of illicit opioids such as heroin and fentanyl [4].

Healthcare providers play a crucial role in preventing opioid misuse by implementing evidence-based prescribing guidelines, conducting thorough assessments of patients' pain and risk factors, and educating patients about the potential risks and benefits of opioids. Implementing prescription drug monitoring programs and using electronic health records can also help identify patients at risk for opioid misuse and facilitate appropriate interventions [5].

Increasing access to alternative pain management modalities, such as physical therapy, acupuncture, chiropractic care, cognitive-behavioral therapy, and non-opioid medications, can reduce reliance on opioids for pain relief. Integrative approaches that combine multiple modalities tailored to individual patient needs can effectively manage pain while minimizing the risk of opioid-related harm [6].

Raising public awareness about the risks of prescription opioid use and the signs of opioid misuse and addiction is essential for prevention and early intervention. Educational campaigns targeting patients, healthcare providers, policymakers, and the general public can help dispel misconceptions about opioids, reduce stigma surrounding addiction, and promote safe prescribing and medication disposal practices [7].

Expanding access to evidence-based treatment and support services for individuals with opioid use disorder is critical for reducing overdose deaths and promoting long-term recovery. Addressing the opioid crisis requires a multifaceted approach that addresses the complex interplay of factors contributing to opioid misuse and addiction [8].

This includes increasing availability of medication-assisted treatment (MAT) with medications such as methadone, buprenorphine, and naltrexone, as well as providing comprehensive addiction treatment, counseling, peer support, and harm reduction services [9].

Additionally, patients may develop tolerance and physical dependence on opioids even when taken as prescribed, increasing the risk of misuse and addiction over time. Prescription opioids are a class of medications primarily used to manage moderate to severe pain. Commonly prescribed opioids include oxycodone, hydrocodone, morphine, and fentanyl [10].


The complexities of prescription opioid use demand a comprehensive and coordinated response that addresses the multifaceted nature of the opioid crisis. By implementing strategies to enhance prescribing practices, expand access to non-opioid pain management, improve education and awareness, and increase access to treatment and support services, we can mitigate the harms associated with prescription opioids and prevent further escalation of the opioid epidemic. Collaborative efforts involving healthcare providers, policymakers, community organizations, and individuals affected by opioid use disorder are essential for achieving meaningful progress in combating this public health crisis.


  1. Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, Marshall BD, Tyndall M, Walsh SL. Opioid use disorder. Nat Rev Dis Primers. 2020;6(1):3.
  2. Google Scholar

  3. Sharma B, Bruner A, Barnett G, Fishman M. Opioid use disorders. Child Adolesc Psychiatr Clin N. 2016;25(3):473-87.
  4. Google Scholar, Cross Ref

  5. Kelly JP, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138(3):507-13.
  6. Indexed at, Google Scholar, Cross Ref

  7. Blanco C, Volkow ND. Management of opioid use disorder in the USA: present status and future directions. The Lancet. 2019;393(10182):1760-72.
  8. Indexed at, Google Scholar, Cross Ref

  9. Schuchat A, Houry D, Guy GP. New data on opioid use and prescribing in the United States. Jama. 2017;318(5):425-6.
  10. Indexed at, Google Scholar, Cross Ref

  11. Pergolizzi Jr JV, Raffa RB, Rosenblatt MH. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management. J Clin Pharm Ther. 2020;45(5):892-903.
  12. Indexed at, Google Scholar, Cross Ref

  13. Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BD, Bruneau J, Altice FL, Henderson G, Rahimi-Movaghar A, Larney S. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. The Lancet. 2019;394(10208):1560-79.
  14. Indexed at, Google Scholar, Cross Ref

  15. Webster LR. Risk factors for opioid-use disorder and overdose. Anesth 2017;125(5):1741-8.
  16. Indexed at, Google Scholar, Cross Ref

  17. Wilder-Smith OH. Opioid use in the elderly. Eur J Pain. 2005;9(2):137-40.
  18. Indexed at, Google Scholar

  19. Nelson LS, Juurlink DN, Perrone J. Addressing the opioid epidemic. Jama. 2015;314(14):1453-4.
  20. Indexed at, Google Scholar

Get the App